Clinical Trials Browser

Phase 2 × INDUSTRY × Palonosetron × Clear all

NCT06904235 2025-07-28

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

Nausea, Vomiting

NCT04592198 2025-03-24

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Phase 2 Completed

22 enrolled 8 charts

Nausea With Vomiting Chemotherapy-Induced

NCT03204279 2024-06-25

CINV

Phase 2 Completed

67 enrolled 12 charts

Vomiting

NCT00306735 2016-12-05

Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.

Phase 2 Completed

Multiple Myeloma

NCT01909856 2015-12-04

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Phase 2 Completed

Neoplasms